期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Anti-atherosclerotic effects and molecular targets of ginkgolide B from Ginkgo biloba
1
作者 Weile Ye Jiaojiao Wang +10 位作者 Peter JLittle Jiami Zou Zhihua Zheng Jing Lu yanjun yin Hao Liu Dongmei Zhang Peiqing Liu Suowen Xu Wencai Ye Zhiping Liu 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2024年第1期1-19,共19页
Bioactive compounds derived from herbal medicinal plants modulate various therapeutic targets and signaling pathways associated with cardiovascular diseases(CVDs),the world’s primary cause of death.Ginkgo biloba,a we... Bioactive compounds derived from herbal medicinal plants modulate various therapeutic targets and signaling pathways associated with cardiovascular diseases(CVDs),the world’s primary cause of death.Ginkgo biloba,a well-known traditional Chinese medicine with notable cardiovascular actions,has been used as a cardio-and cerebrovascular therapeutic drug and nutraceutical in Asian countries for centuries.Preclinical studies have shown that ginkgolide B,a bioactive component in Ginkgo biloba,can ameliorate atherosclerosis in cultured vascular cells and disease models.Of clinical relevance,several clinical trials are ongoing or being completed to examine the efficacy and safety of ginkgolide B-related drug preparations in the prevention of cerebrovascular diseases,such as ischemia stroke.Here,we present a comprehensive review of the pharmacological activities,pharmacokinetic characteristics,and mechanisms of action of ginkgolide B in atherosclerosis prevention and therapy.We highlight new molecular targets of ginkgolide B,including nicotinamide adenine dinucleotide phosphate oxidases(NADPH oxidase),lectin-like oxidized LDL receptor-1(LOX-1),sirtuin 1(SIRT1),platelet-activating factor(PAF),proprotein convertase subtilisin/kexin type 9(PCSK9)and others.Finally,we provide an overview and discussion of the therapeutic potential of ginkgolide B and highlight the future perspective of developing ginkgolide B as an effective therapeutic agent for treating atherosclerosis. 展开更多
关键词 Cardiovascular disease Atherosclerosis Ginkgo biloba Ginkgolide B Endothelial dysfunction LOX-1 PCSK9 PAF-R antagonist
原文传递
Fe-Mn interdiffusion in aluminosilicate garnets
2
作者 yanjun yin Baohua Zhang Xinzhuan Guo 《Geoscience Frontiers》 SCIE CAS CSCD 2024年第1期118-125,共8页
Precise determination of cation diffusivity in garnet can provide critical information for quantitatively understanding the timescales and thermodynamics of various geological processes,but very few studies have been ... Precise determination of cation diffusivity in garnet can provide critical information for quantitatively understanding the timescales and thermodynamics of various geological processes,but very few studies have been performed for Fe-Mn interdiffusion.In this study,Fe-Mn interdiffusion rates in natural single crystals of Mn-bearing garnet with 750 ppm H2O are determined at 6 GPa and 1273-1573 K in a Kawai-type multi-anvil apparatus.Diffusion profiles were acquired by electron microprobe and fitted using Boltzmann-Matano equation.The experimental results show that the Fe-Mn interdiffusion coefficient(DFe-Mn)slightly decreases with increasing XFe.The experimentally determined DFe-Mn in Mn-bearing garnet can be fitted by the Arrhenius equation:DFe-Mn(m2/s)=D0XFenexp(-E*/RT),where E*=(1-XFe)E*Mn+XFeE*Fe,D0=8.06-6.04+9.87×10-9 m2/s,E*Mn=248±27 KJ/mol,E*Fe=226±59 KJ/mol,n=-1.36±0.51.The comparing the present results with previous experimental data suggest that water can greatly enhance the DFe-Mn in garnet.Our results indicate that the time required for homogenization of the compositional zoning of a garnet is much shorter than previously thought. 展开更多
关键词 Fe-Mn interdiffusion Diffusion coefficient GARNET High pressure experiment Water
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部